Firas Zahwe, MD
Clinical Cardiac Electrophysiology · Warren, MINPI 1093941395
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 39.8% of the total. Reporting peaked in 2024 at $11,396 and has fallen 69.2% since, to $3,508 in 2025.
Across 283 payments — averaging $76.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$9K
- Abbott$6K
- Biosense Webster, Inc.$2K
- Medtronic$1K
- Altathera Pharmaceuticals LLC$1K
- Boston Scientific$664
- plus $2K from 20 others
Across 9 payments — averaging $1441.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$13K
What the payments were for
- Speaking & faculty fees$8,50040%
- Travel & lodging$2,36311%
- Food & beverage$10,65050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 52 | $8,561 |
| Abbott | 59 | $6,061 |
| Biosense Webster, Inc. | 34 | $1,588 |
| Medtronic(2 entities) | 43 | $1,429 |
| Altathera Pharmaceuticals LLC | 4 | $1,070 |
| Boston Scientific | 24 | $664 |
| Atricure, Inc. | 5 | $440 |
| Kestra Medical Technology Services, Inc. | 7 | $349 |
| Cardiva Medical, Inc. | 15 | $212 |
| E.r. Squibb & Sons, L.L.C. | 12 | $171 |
| Shockwave Medical, Inc | 1 | $125 |
| Johnson & Johnson | 3 | $121 |
| Alnylam Pharmaceuticals Inc. | 1 | $117 |
| Biotronik Inc. | 1 | $111 |
| Pfizer | 5 | $107 |
| Elutia, Inc. | 2 | $72 |
| Philips North America LLC | 3 | $67 |
| Novo Nordisk | 3 | $61 |
| Getinge USA Sales, LLC | 2 | $56 |
| Novartis | 1 | $27 |
| Bardy Diagnostics, Inc. | 1 | $25 |
| Haemonetics Corporation | 1 | $18 |
| Chiesi USA, Inc. | 1 | $16 |
| Cordis US CORP. | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$7,727
- AVEIR$2,226
- Sotalol Hydrochloride$1,000
- AMPLATZER AMULET$896
- Carto 3$548
- ENSITE PRECISION$411
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$307
- ATRICLIP LAA EXCLUSION SYSTEM$307
- ENSITE$299
- EnSite Velocity System Mapping D$245
- Ensite Cardiac Mapping System$174
- AGILIS$170
- WATCHMAN FLX$149
- GALLANT$149
- QDOT MICRO Catheter$145
- AFFERA MAPPING SYSTEM$142
- ARCTIC FRONT ADVANCE$134
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$133
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$125
- Assure WCD$123
How this compares
$21,513 in reported general payments places this provider in the 60th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
See all clinical cardiac electrophysiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 127 | $113,603 |
| XareltoRivaroxaban | 15 | $14,804 |
| Metoprolol Succinate | 131 | $2,211 |
| Amiodarone Hcl | 104 | $1,482 |
| Flecainide Acetate | 28 | $1,048 |
| Losartan Potassium | 35 | $486 |
| SotalolSotalol Hcl | 15 | $451 |
| Pantoprazole Sodium | 37 | $366 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $353 |
| Colchicine | 38 | $214 |
| Carvedilol | 14 | $165 |
| Amlodipine Besylate | 17 | $120 |
| Furosemide | 15 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $107 | $113,603127 claims |
| Johnson & JohnsonXarelto | $121 | $14,80415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
Other clinical cardiac electrophysiology in Warren
- Randy LiebermanDetroit$1.2M
- Asim YunusSaginaw$236K
- Jackson LiangAnn Arbor$229K
- Ryan CunnaneAnn Arbor$218K
- Dipak ShahSouthfield$194K
- Rakesh LatchamsettyBrighton$165K
- Ilana KutinskyTroy$138K
- Nishaki MehtaRoyal Oak$133K
- Andre GauriGrand Rapids$126K
- Daniel AlyeshAnn Arbor$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.